François Donat

444 total citations
9 papers, 341 citations indexed

About

François Donat is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, François Donat has authored 9 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Hematology and 3 papers in Internal Medicine. Recurrent topics in François Donat's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). François Donat is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). François Donat collaborates with scholars based in France, United States and Sweden. François Donat's co-authors include J Necciari, Christine Gaud, R Cariou, M Samama, Nicolas Piriou, Alain Vuillemenot, J. Bouthier, Mohamed El Hajji, Jean‐Marc Herbert and Philippe Duchaussoy and has published in prestigious journals such as British Journal of Pharmacology, Thrombosis and Haemostasis and British Journal of Clinical Pharmacology.

In The Last Decade

François Donat

9 papers receiving 317 citations

Peers

François Donat

CCM

IM

SURGE

HEMAT

PHARM

JM Herbert France

JP Maffrand France

Denis Delebassée France

G Kieffer France

Natalia Dovlatova United Kingdom

Orsolya Rideg Hungary

Julie K. Brooks United States

Wolfgang G. Eisert Germany

Haidar Maatouk Germany

Stan Kurowski United States

JM Herbert France

François Donat

256 ×1.1

CCM

95 ×0.7

IM

101 ×0.9

SURGE

70 ×1.2

HEMAT

67 ×1.5

PHARM

Citations per year, relative to François Donat François Donat (= 1×) peers JM Herbert

Countries citing papers authored by François Donat

Since Specialization

Citations

This map shows the geographic impact of François Donat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Donat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Donat more than expected).

Fields of papers citing papers by François Donat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Donat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Donat. The network helps show where François Donat may publish in the future.

Co-authorship network of co-authors of François Donat

This figure shows the co-authorship network connecting the top 25 collaborators of François Donat. A scholar is included among the top collaborators of François Donat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Donat. François Donat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Cortez, Pierre, et al.. (2012). Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis. British Journal of Clinical Pharmacology. 75(5). 1255–1264. 4 indexed citations

2.

Paolucci, F, et al.. (2003). Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices.. PubMed. 49(9-10). 451–60. 26 indexed citations

3.

Petitou, Maurice, Philippe Duchaussoy, Jean‐Marc Herbert, et al.. (2002). The Synthetic Pentasaccharide Fondaparinux: First in the Class of Antithrombotic Agents that Selectively Inhibit Coagulation Factor Xa. Seminars in Thrombosis and Hemostasis. 28(4). 393–402. 63 indexed citations

4.

Donat, François, et al.. (1999). Pharmacokinetics of clopidogrel.. PubMed. 25 Suppl 2. 25–8. 133 indexed citations

5.

Vuillemenot, Alain, et al.. (1999). Efficacy of a Synthetic Pentasaccharide, a Pure Factor Xa Inhibitor, as an Antithrombotic Agent – A Pilot Study in the Setting of Coronary Angioplasty. Thrombosis and Haemostasis. 81(2). 214–220. 59 indexed citations

6.

Brouard, R., et al.. (1998). Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1A Vasopressin Receptor Antagonist, After Repeated Oral Administration in Healthy Volunteers. Advances in experimental medicine and biology. 449. 455–465. 18 indexed citations

7.

Larsson, Rutger, et al.. (1997). Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function. The Journal of Clinical Pharmacology. 37(2). 108–115. 14 indexed citations

8.

Donat, François, et al.. (1997). Pharmacokinetic study of three synthetic AT-binding pentasaccharides in various animal species-extrapolation to humans. Blood Coagulation & Fibrinolysis. 8(3). 161–167. 9 indexed citations

9.

Roccon, Alain, et al.. (1994). A pharmacodynamic study of SR 47436, a selective AT₁ receptor antagonist, on blood pressure in conscious cynomolgus monkeys. British Journal of Pharmacology. 111(1). 145–150. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact